Discover

GLP
Global Partners LP
50.01
1 x 49.21
1 x 54.81
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
50.01 +0.00 (0.00%)
Ytd19.50%
1y2.06%
48.83
day range
50.08
39.58
52 week range
53.25
Open49.60Prev Close50.01Low48.83High50.08Mkt Cap1.70B
Vol110.18KAvg Vol109.92KEPS3.60P/E13.89Forward P/E19.83
Beta1.01Short Ratio0.84Inst. Own49.91%Dividend3.12Div Yield6.22
Ex Div Date08-10Earning08-0650-d Avg47.79200-d Avg46.221yr Est45.00

GLP News

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
marketbeat.com
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Omada Health NASDAQ: OMDA highlighted record second-quarter revenue and margin performance at the Ca

GLP Q2 Earnings Call Flags Hedging Costs Amid Strong Fuel Margins
zacks.com
GLP Q2 Earnings Call Flags Hedging Costs Amid Strong Fuel Margins

Global Partners flags higher hedged-inventory carrying costs from steep backwardation, even as stron

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?
fool.com
Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Eli Lilly leads the GLP-1 market and could remain on top thanks to a deep pipeline. Viking Therapeut

Global Partners Q2 Earnings Call Highlights
marketbeat.com
Global Partners Q2 Earnings Call Highlights

Global Partners NYSE: GLP reported higher second-quarter earnings and cash flow as stronger gasoline

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)
seekingalpha.com
Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics (VKTX) maintains a Hold rating as competitive pressures intensify in the GLP-1 o

Global Partners LP Common Units (GLP) Q2 2026 Earnings Call Transcript
seekingalpha.com
Global Partners LP Common Units (GLP) Q2 2026 Earnings Call Transcript

Global Partners LP Common Units (GLP) Q2 2026 Earnings Call Transcript

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
prnewswire.com
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1

Initiation of study marks an important milestone in advancing Neurocrine's obesity portfolio and inv

Global Partners LP Reports Second-Quarter 2026 Financial Results
businesswire.com
Global Partners LP Reports Second-Quarter 2026 Financial Results

NEWTON, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) today reported financial results for

Amazon.com said patients with Medicare Part D prescription plans now have access to certain GLP-1 weight-loss medications through Amazon Pharmacy
wsj.com
Amazon.com said patients with Medicare Part D prescription plans now have access to certain GLP-1 we

Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo will be available at a cost of $50 a mon

Wednesday's Final Takeaways: GOOGL AI Chief Leaves, GLP-1 Boosts LLY
youtube.com
Wednesday's Final Takeaways: GOOGL AI Chief Leaves, GLP-1 Boosts LLY

Marley Kayden and Sam Vadas wrap up Wednesday's session with a few overlooked headlines to keep on t

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
marketwatch.com
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the h

The Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
cnbc.com
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America CEO Brian Moynihan said the company is spending more than $250 million annually to p

Global Partners Gears Up for Q2 Earnings: What's in the Cards?
zacks.com
Global Partners Gears Up for Q2 Earnings: What's in the Cards?

GLP enters Q2 with wholesale momentum and resilient fuel margins, while inventory costs and softer f

GLP-1's Drove Eli Lilly's Record-Breaking Q2, but AI Will Be Its Future
247wallst.com
GLP-1's Drove Eli Lilly's Record-Breaking Q2, but AI Will Be Its Future

The market has spent the past two years treating pharmaceutical stocks like a referendum on GLP-1 dr

Eli Lilly Stock Rises as GLP-1 Demand Drives Beat-and-Raise
schaeffersresearch.com
Eli Lilly Stock Rises as GLP-1 Demand Drives Beat-and-Raise

Eli Lilly (NYSE:LLY) is higher ahead of the open, up 4.8% to trade at $1,169, after the pharmaceutic

Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
wsj.com
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand

Eli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging

CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases
wsj.com
CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases

CVS Health said it will revamp its weight management program through a partnership with Eli Lilly as

CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
prnewswire.com
CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordabil

CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options. New coll

GLP-1 Demand Is Creating a New Dividend Angle in These 4 Logistics Stocks
marketbeat.com
GLP-1 Demand Is Creating a New Dividend Angle in These 4 Logistics Stocks

Many investors share the quality of being curious. That lends itself to viewing the world in a parti

Citi says Novo selloff overdone but GLP-1 worries keep it on the sidelines
proactiveinvestors.co.uk
Citi says Novo selloff overdone but GLP-1 worries keep it on the sidelines

Citi has kept its 'neutral' rating on Novo Nordisk (NYSE:NVO), arguing that the market's reaction to

Earnings Scheduled For February 27, 2026
benzinga.com
Earnings Scheduled For February 27, 2026

Nasdaq Down Over 1% As Nvidia Shares Fall: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
benzinga.com
Nasdaq Down Over 1% As Nvidia Shares Fall: Investor Sentiment Declines, Greed Index Moves To 'Fear'

Market sentiment declines, Nasdaq falls 1%. Nvidia down 5%, Salesforce up 4% in earnings. Initial jo

Dell, Block And 3 Stocks To Watch Heading Into Friday
benzinga.com
Dell, Block And 3 Stocks To Watch Heading Into Friday

U.S. stock futures lower, Carter's and Dell report earnings, Global Partners and Block announce

Earnings Scheduled For November 7, 2025
benzinga.com
Earnings Scheduled For November 7, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For February 28, 2025

benzinga.com
Earnings Scheduled For February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Earnings Scheduled For August 4, 2023

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first

benzinga.com
Earnings Scheduled For May 5, 2023

Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly e

benzinga.com
Earnings Scheduled For February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly ear

benzinga.com
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on M

benzinga.com
Earnings Scheduled For February 28, 2022

  Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    During Wednesday's morning trading, 251 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

    Tuesday morning saw 244 companies set new 52-week highs.

benzinga.com
70 Biggest Movers From Friday

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.

benzinga.com
56 Stocks Moving In Friday's Mid-Day Session

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    Wednesday's morning session saw 275 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

    Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    Monday's morning session saw 253 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Friday

    Friday's morning session saw 136 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

    Before 10 a.m. ET on Thursday, 441 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    On Monday morning, 415 companies achieved new highs for the year.

benzinga.com
Stocks That Hit 52-Week Highs On Friday

    Before 10 a.m. ET on Friday, 571 companies hit new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

  On Tuesday morning, 172 companies achieved new highs for the year.

benzinga.com
Earnings Scheduled For November 5, 2020

  Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday